Assignee
ARTAX BIOPHARMA INC
US·8 granted patents·1 pending application·15 citations·filing 2014–2025
Top patents by PatentIndex Score
9 records- 0186US11807633B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2021·Granted Nov 7, 2023·1 cites·20 claims
- 0284US10696663B2Chromene derivatives as inhibitors of TCR-NCK interactionARTAX BIOPHARMA INC·Filed 2019·Granted Jun 30, 2020·2 cites·21 claims
- 0383US12319675B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2023·Granted Jun 3, 2025·0 cites·2 claims
- 0482US11008310B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2020·Granted May 18, 2021·1 cites·22 claims
- 0578US2025346586A1Chromene derivatives as inhibitors of tcr-nck interactionARTAX BIOPHARMA INC·Filed 2025·Application pending·0 cites
- 0676US10131647B2Chromene derivatives substituted by alkoxide as inhibitors of the TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2014·Granted Nov 20, 2018·6 cites·22 claims
- 0775US10106518B2Chromene derivatives as inhibitors of TCR-Nck interactionARTAX BIOPHARMA INC·Filed 2014·Granted Oct 23, 2018·5 cites·20 claims
- 0845US11434239B2Aza-dihydro-acridone derivativesARTAX BIOPHARMA INC·Filed 2018·Granted Sep 6, 2022·0 cites·26 claims
- 0944US11505526B2Aryl-piperidine derivativesARTAX BIOPHARMA INC·Filed 2018·Granted Nov 22, 2022·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when ARTAX BIOPHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →